Axa S.A. Autolus Therapeutics PLC Transaction History
Axa S.A.
- $33.6 Billion
- Q2 2025
A detailed history of Axa S.A. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Axa S.A. holds 3,126,167 shares of AUTL stock, worth $4.97 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,126,167
Previous 3,126,167
-0.0%
Holding current value
$4.97 Million
Previous $4.85 Million
47.1%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
164MCall Options Held
0Put Options Held
39.3K-
Wellington Management Group LLP Boston, MA27.1MShares$43.2 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$32.6 Million0.22% of portfolio
-
Mak Capital One LLC New York, NY17MShares$27 Million5.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT16.9MShares$26.8 Million1.36% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$26.5 Million98.24% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $145M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...